Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion type Assertion NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_head.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_provenance.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion evidence source_evidence_literature NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_provenance.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion SIO_000772 11926891 NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_provenance.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion wasDerivedFrom befree-2016 NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_provenance.
- NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_assertion wasGeneratedBy ECO_0000203 NP350333.RA9aoeF-dVJXwhYhN0VQEDkIKddWPGRnv0C9J4PbInbjs130_provenance.